The goal of this program is to provide veterinary team members tools and techniques that guide supportive yet realistic conversations about cancer with pet owners.

Supporting Pet Owners when Cancer is the Diagnosis: Practical Communication Strategies for the Veterinary Team

Practical Communication Strategies for the Veterinary Team

Selective inhibition of nuclear export (SINE) class drugs are small molecules recently introduced to both human and veterinary oncology. This course explores how SINE drugs introduce new ways to think about managing cancer and how they may be integrated into the treatment of several neoplastic diseases.

The Science Behind SINE Class Drugs

Novel Small Molecules for Oncology

In this CE session, we’ll review the latest research on Valley Fever in dogs and cats, including its biology, clinical disease manifestations, diagnosis, differentials, and treatment as well as promising work towards the development of a preventive vaccine.

Valley Fever In Dogs and Cats

Think Outside the Desert

As a veterinary technician, you’re an integral part of the patient care team and a primary client contact for even the most heart-wrenching cases. In this session, we’ll review current best practices for managing canine lymphoma patients, including current diagnostics and treatment options as well as guidelines for helping clients navigate difficult decisions. We will also address the importance of recognizing your personal response to patient loss and practicing self-care.

A Vet Tech's Guide to Canine Lymphoma

Coccidioidomycosis, also known as “Valley Fever,” is a systemic fungal disease caused by the inhalation of Coccidioides spp. soil fungi, C.posadasii and C.immitis. Coccidioidomycosis causes a great deal of morbidity and mortality in affected patients and can also infect humans. To date, the only available prevention for this disease is avoidance of endemic areas. Progress is being made towards the development of a viable systemic vaccine against Coccidioides spp. in the dog. In this program, we will review the increasing geographic spread of Valley Fever, our current understanding of the protective host immune response to Coccidioides spp. infection, and review scientific studies leading us towards a potential vaccine to prevent the disease in dogs.

Advances in Vaccine Technology - Pioneering a Preventive for Valley Fever

Pioneering a Preventive for Valley Fever in Dogs

In this CE session, we’ll review the latest best practices for managing canine lymphoma. We’ll also talk about how the first FDA conditionally approved oral tablet for canine lymphoma, LAVERDIA™-CA1 (verdinexor), is giving veterinarians and dog owners more options and increasing access to cancer care.

Verdinexor: A new oral treatment option for canine lymphoma

Latest Best Practices for Managing Canine Lymphoma

Coccidioidomycosis, also known as "Valley Fever," is a systemic fungal disease caused by the inhalation of Coccidioides spp. soil fungi, C. posadasii and C. immitis. Coccidioidomycosis causes a great deal of morbidity and mortality in affected patients and can also infect humans. To date, the only available prevention for this disease is avoidance of endemic areas. Progress is being made towards development of a viable systemic vaccine against Coccidioides spp. in the dog. In this program, we will review details regarding Valley Fever pertinent to vaccine development including its dimorphic life cycle, geographic distribution and our current understanding of the protective host immune response to systemic Coccidioides infections. This course takes a detailed look at the scientific studies that are leading us towards a potential vaccine to prevent the disease in dogs.

Advances in Vaccine Technology - Pioneering a Preventive for Valley Fever (Extended Version)

Pioneering a Preventive for Valley Fever

Feline Infectious Peritonitis (FIP) is a progressive and almost always fatal disease without treatment. There are currently no FDA approved medications for the treatment of FIP, however new research looking into the use of antivirals holds some hope for the future.&nbsp; This course will provide a brief background on FIP including the history of coronaviruses and the epidemiology, diagnosis of and current treatment options for FIP.&nbsp; We will then explore ongoing research into promising new treatment modalities, including immunostimulants and antivirals.

Continuing Education

Valley Fever In Dogs and Cats

Think Outside the Desert

Valley Fever In Dogs and Cats

Think Outside the Desert

In this CE session, we’ll review the latest research on Valley Fever in dogs and cats, including its biology, clinical disease manifestations, diagnosis, differentials, and treatment as well as promising work towards the development of a preventive vaccine.

Supporting Pet Owners when Cancer is the Diagnosis: Practical Communication Strategies for the Veterinary Team

Practical Communication Strategies for the Veterinary Team

The Science Behind SINE Class Drugs

Novel Small Molecules for Oncology

A Vet Tech's Guide to Canine Lymphoma

Practical Communication Strategies for the Veterinary Team

Advances in Vaccine Technology - Pioneering a Preventive for Valley Fever

Pioneering a Preventive for Valley Fever in Dogs

Verdinexor: A new oral treatment option for canine lymphoma

Latest Best Practices for Managing Canine Lymphoma

Advances in Vaccine Technology - Pioneering a Preventive for Valley Fever (Extended Version)

Pioneering a Preventive for Valley Fever

What the future holds: new hope on the horizon for FIP

New hope on the horizon for FIP

Request a meeting with your Anivive Representative